Uchiyama Nahoko, Kim Ik Hwi, Kikura-Hanajiri Ruri, Kawahara Nobuo, Konishi Tenji, Goda Yukihiro
National Institute of Health Sciences, Tokyo 158-8501, Japan.
J Pharm Biomed Anal. 2008 Apr 14;46(5):864-9. doi: 10.1016/j.jpba.2007.04.004. Epub 2007 Apr 8.
Flavanone glycosides, such as naringin and neohesperidin, are distributed in some Citrus species and have a chiral center in the C-2 position of the flavanone moiety. Naringin and neohesperidin (2S-form) were separated from the corresponding C-2 epimers (2R-epi-form) by normal-phase HPLC using a polysaccaride-derived chiral stationary phases (CSPs), CHIRALPAK IB. The analyses of commercial samples of naringin revealed that the relative ratios of naringin to the C-2 epimer were 29-89%. In the case of a commercial sample of neohesperidin, the relative ratio of the neohesperidin (2S-form) is 84%. The HPLC application to Citrus species used as crude drugs in Japan (Kijitsu, Kikoku and Tohi) showed that the relative ratios of naringin to the C-2 epimer were 75-93% in Kijitsu, 74-79% in Kikoku and 54-64% in Tohi. However, there is a quite small ratio of the (2R)-epi-neohesperidin in Citrus. This result suggested that the averages of relative ratio of (2S)-naringin in Citrus species reduced according to the maturity of fruits (Kijitsu<Kikoku<Tohi). Since the relative ratios of (2S)-naringin of dry extracts of 5 Kampo formulations (including Kijitsu or Kikoku) decreased to 42-54%, the conversion from naringin to the (2R)-epimer might be enhanced during the decoction process of the formulations.
黄酮醇苷,如柚皮苷和新橙皮苷,分布于一些柑橘属植物中,且在黄酮醇部分的C-2位具有一个手性中心。使用多糖衍生的手性固定相(CSPs)CHIRALPAK IB,通过正相高效液相色谱法将柚皮苷和新橙皮苷(2S-型)与相应的C-2差向异构体(2R-表型)分离。对市售柚皮苷样品的分析表明,柚皮苷与C-2差向异构体的相对比例为29%-89%。对于市售新橙皮苷样品,新橙皮苷(2S-型)的相对比例为84%。对日本用作药材的柑橘属植物(枳实、枳壳和橙皮)进行的高效液相色谱分析表明,枳实中柚皮苷与C-2差向异构体的相对比例为75%-93%,枳壳中为74%-79%,橙皮中为54%-64%。然而,柑橘属植物中(2R)-表新橙皮苷的比例相当小。这一结果表明,柑橘属植物中(2S)-柚皮苷的相对比例平均值会随着果实成熟度降低(枳实<枳壳<橙皮)。由于5种汉方制剂(包括枳实或枳壳)干提取物中(2S)-柚皮苷的相对比例降至42%-54%,在制剂煎煮过程中,柚皮苷向(2R)-差向异构体的转化可能会增强。